Le Lézard
Classified in: Business
Subjects: SVY, PET

Spot Pet Insurance Reveals Seasonal Allergy Surge in Dogs & Cats


About 10-15% of population affected by seasonal allergies

MIAMI, April 11, 2024 /PRNewswire/ -- As humans gear up for allergy season, it's essential to remember that our furry friends are also susceptible to seasonal allergies. Spot Pet Insurance, a leading provider of pet insurance, has analyzed its data and found a significant spike in claims for Cytopoint and Apoquel, common treatments for itchy skin and seasonal allergies in pets, starting in May and continuing through November.1

Seasonal allergies affect approximately 10-15% of the dog and cat population, causing discomfort and distress to our beloved pets.2 Spot Pet Insurance's data team examined claims involving Cytopoint injections and Apoquel medication, revealing a consistent increase during allergy season. While Apoquel can be used for both dogs and cats, Cytopoint is exclusively for dogs.

"Common allergens aren't just a problem for humans; it can also wreak havoc on our pets' health," said Trey Ferro, CEO of Spot Pet Insurance. "As responsible pet owners, it's crucial to be mindful of pet allergies, provide proper care, and recognize signs of distress."

Common Symptoms
Common symptoms of environmental allergies in dogs and cats include itching, scratching, chewing on paws, redness or inflammation of the skin, sneezing, and watery eyes. Left untreated, allergies can potentially lead to secondary skin infections and other health complications.

Tips to Help Your Pet Combat Seasonal Allergies

"While we can't eliminate allergens entirely, we can take steps to help minimize their impact on our pets," added Ferro. "Spot Pet Insurance is committed to helping provide peace of mind to pet owners by offering coverage for essential treatments like Cytopoint and Apoquel, ensuring that pets can receive the care they need to thrive."

Please note that Spot Pet Insurance plans do not cover pre-existing conditions. For more information about Spot Pet Insurance and its coverage options, visit spotpet.com.

About Spot Pet Insurance:
Spot Pet Insurance is a passionate team of pet-health-obsessed pet parents driven by a shared vision to educate, empower, and engage pet lovers about the benefits of pet insurance. They aim to help pet owners pay for covered veterinary bills, helping to ensure that their dogs and cats can lead healthier, happier lives.

To learn more about Spot Pet Insurance, please visit spotpet.com.

Sources:

  1. 2023 PTZ Insurance Agency Ltd. claims data.
  2. "Dog and Cat Seasonal Allergies," Ethos Veterinary Health, https://www.ethosvet.com/blog-post/seasonal-allergies-in-pets/, Apr. 26, 2023.

Independent and paid ad from Spot Pet Insurance.
Waiting periods, annual deductible, co-insurance, benefit limits and exclusions may apply. For all terms visit spotpetins.com/sample-policy. Products, schedules, discounts, and rates may vary and are subject to change. More information available at checkout.

Insurance plans are underwritten by either Independence American Insurance Company (NAIC #26581. A Delaware insurance company located at 11333 N. Scottsdale Rd, Ste. 160, Scottsdale, AZ 85254) or United States Fire Insurance Company (NAIC #21113. Morristown, NJ), and are produced by Spot Pet Insurance Services, LLC. (NPN # 19246385. 990 Biscayne Blvd Suite 603, Miami, FL 33132. CA License #6000188).

The information presented in this article is for educational and informational purposes only and does not constitute or substitute for the advice of your veterinarian.

Contact:
Cassidy Laudano 
1-224-433-0858 
[email protected]

SOURCE Spot Pet Insurance


These press releases may also interest you

at 03:41
TDR Capital and I Squared Capital are pleased to announce their successful offer for the Spanish certification company, Applus Services S.A. Applus is one of the world's leading testing, inspection and certification (TIC) companies. Applus reported...

at 03:38
Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January ? March...

at 03:30
CLEVR is delighted to announce that PREMIUM INC. a Dutch house of athleisure-wear brands has selected and implemented the Mendix Digital Lifecycle Management for Fashion & Retail solution to help support its expansion. The entrepreneurial culture and...

at 03:00
ISX Financial EU PLC ("ISXPlc"), is pleased to present its earnings for Q1 2024. Building on the back of a record Q4 23, ISXPlc is pleased to have delivered yet another record breaking quarter, marking a continuation of its upward trajectory and...

at 03:00
ShapeBlue, a leader in delivering CloudStack engineering services and support, announces a partnership with proIO, a German Private Cloud Provider empowering SMBs across various industries through its Infrastructure-as-a-Service and Managed Hosting...

at 03:00
SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab...



News published on and distributed by: